WST
West Pharmaceutical Services, Inc.
Stock
$364.98−0.03 (−0.01%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.1B | $2.9B | $2.9B | $2.9B | $2.8B | $2.1B | $1.8B | $1.7B | $1.6B | $1.5B | $1.4B | $1.4B | $1.4B | $1.3B | $1.2B | $1.1B | $1.1B | $1.1B |
| Cost of revenue | $2.1B | $2.0B | $1.9B | $1.8B | $1.8B | $1.7B | $1.4B | $1.2B | $1.2B | $1.1B | $1.0B | $944M | $974M | $934M | $879M | $853M | $787M | $752M | $749M |
| Gross profit | $1.2B | $1.1B | $999M | $1.1B | $1.1B | $1.2B | $768M | $606M | $545M | $513M | $501M | $456M | $448M | $435M | $388M | $339M | $318M | $304M | $303M |
| R&D | $74M | $74M | $69M | $68M | $59M | $53M | $47M | $39M | $40M | $39M | $37M | $34M | $37M | $38M | $33M | $29M | $24M | $20M | $19M |
| SG&A | $427M | $394M | $339M | $353M | $317M | $363M | $302M | $273M | $263M | $246M | $240M | $233M | $229M | $235M | $218M | $191M | $188M | $178M | $159M |
| Other operating expenses | $42M | $51M | $21M | $31M | $27M | $7.9M | $12M | — | $1.9M | $2.0M | $30M | $60M | — | — | $1.3M | $9.5M | $16M | $8.5M | — |
| Operating income | $680M | $585M | $570M | $676M | $734M | $752M | $407M | $297M | $240M | $226M | $195M | $129M | $182M | $162M | $135M | $110M | $91M | $98M | $124M |
| Non-operating income | $13M | $16M | $16M | $22M | −$54M | −$3.4M | −$5.6M | −$4.8M | $400K | −$3.4M | −$5.4M | −$13M | −$13M | −$15M | −$27M | −$17M | −$16M | −$14M | −$15M |
| Pretax income | $694M | $601M | $586M | $698M | $680M | $749M | $401M | $292M | $241M | $222M | $190M | $116M | $169M | $147M | $109M | $93M | $75M | $83M | $110M |
| Taxes | $129M | $107M | $93M | $105M | $94M | $87M | $55M | $50M | $34M | $72M | $46M | $21M | $42M | $35M | $28M | $17M | $9.2M | $11M | $24M |
| Net income | $565M | $494M | $493M | $593M | $586M | $662M | $346M | $242M | $207M | $151M | $144M | $96M | $127M | $112M | $81M | $76M | $65M | $73M | $86M |
| Diluted EPS | $7.81 | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 | $4.57 | $3.21 | $2.74 | $1.99 | $1.91 | $1.30 | $1.75 | $1.57 | $1.15 | $1.08 | $0.95 | $1.06 | $1.25 |
| Diluted shares | — | 72.7M | 73.7M | 75.3M | 75.8M | 76.3M | 75.8M | 75.4M | 75.4M | 75.8M | 75.0M | 73.8M | 72.8M | 71.4M | 71.8M | 74.0M | 73.4M | 72.6M | 72.2M |
| Revenue growth | — | +6.3% | −1.9% | +2.2% | +2.0% | +31.9% | +16.7% | +7.1% | +7.4% | +6.0% | +7.8% | −1.5% | +3.9% | +8.1% | +6.2% | +7.9% | +4.6% | +0.4% | — |
| Gross margin | 36.8% | 35.9% | 34.5% | 38.3% | 39.4% | 41.5% | 35.8% | 32.9% | 31.8% | 32.1% | 33.2% | 32.6% | 31.5% | 31.8% | 30.6% | 28.5% | 28.8% | 28.8% | 28.8% |
| Operating margin | 20.5% | 19.0% | 19.7% | 22.9% | 25.4% | 26.6% | 19.0% | 16.1% | 14.0% | 14.1% | 12.9% | 9.2% | 12.8% | 11.9% | 10.7% | 9.2% | 8.2% | 9.2% | 11.8% |
| Net margin | 17.0% | 16.1% | 17.0% | 20.1% | 20.3% | 23.4% | 16.1% | 13.1% | 12.0% | 9.4% | 9.5% | 6.8% | 8.9% | 8.2% | 6.4% | 6.3% | 5.9% | 6.9% | 8.2% |